Xenetic Biosciences, Inc. Closes $15.0 Million Underwritten Public Offering and Completes Acquisition of Innovative CAR T Technology Platform

Stock Information for Xenetic Biosciences Inc.

Loading

Please wait while we load your information from QuoteMedia.